MRG Group, a diversified business conglomerate, has announced its strategic collaboration with Arica Pharmaceutical, reinforcing its commitment to supporting India’s rapidly growing healthcare sector while fostering innovation, quality, and community well-being.

Established in 2023, Arica Pharmaceutical has built its presence in the pharmaceutical industry with a focus on anti-diabetic, neurosciences, and cardiovascular therapies and is now gearing up to expand into multiple therapeutic categories as part of its long-term growth strategy.

The collaboration is expected to create opportunities for innovation, business expansion, and initiatives aimed at improving healthcare accessibility while strengthening the pharmaceutical ecosystem in India.

Rajjath Goel, Managing Director, MRG Group, said, “Our collaboration with Arica Pharmaceutical reflects our commitment to supporting sectors that have a direct impact on people’s lives. We look forward to working together to drive innovation, encourage responsible growth, and contribute towards building a healthier future for India.”

The leadership of Arica Pharmaceutical expressed confidence that the collaboration with MRG Group will further strengthen the company’s expansion plans and accelerate its vision of becoming a trusted healthcare partner.